Carol L Moore1, Anatole Besarab2, Marie Ajluni3, Vivek Soi4, Edward L Peterson5, Laura E Johnson6, Marcus J Zervos7, Elizabeth Adams4, Jerry Yee4. 1. Divisions of Nephrology and Hypertension, Department of Pharmacy Services, and manierski@wayne.edu. 2. Stanford University, Palo Alto, California; and. 3. Infection Prevention, and. 4. Divisions of Nephrology and Hypertension. 5. Public Health Sciences, Henry Ford Health System, Detroit, Michigan; 6. Infection Prevention, and Infectious Diseases. 7. Infection Prevention, and Infectious Diseases, Wayne State University School of Medicine, Detroit, Michigan.
Abstract
BACKGROUND AND OBJECTIVES: Infection is the second leading cause of death in hemodialysis patients. Catheter-related bloodstream infection and infection-related mortality have not improved in this population over the past two decades. This study evaluated the impact of a prophylactic antibiotic lock solution on the incidence of catheter-related bloodstream infection and mortality. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This prospective, multicenter, observational cohort study compared the effectiveness of two catheter locking solutions (gentamicin/citrate versus heparin) in 555 hemodialysis patients dialyzing with a tunneled cuffed catheter between 2008 and 2011. The groups were not mutually exclusive. Rates of catheter-related bloodstream infection and mortality hazards were compared between groups. RESULTS: The study population (n=555 and 1350 catheters) had a median age of 62 years (interquartile range=41-83 years), with 50% men and 71% black. There were 427 patients evaluable in the heparin period (84,326 days) and 322 patients evaluable in the antibiotic lock period (71,192 days). Catheter-related bloodstream infection in the antibiotic lock period (0.45/1000 catheter days) was 73% lower than the heparin period (1.68/1000 catheter days; P=0.001). Antibiotic lock use was associated with a decreased risk of catheter-related bloodstream infection compared with heparin (risk ratio, 0.23; 95% confidence interval, 0.13 to 0.38 after multivariate adjustment). Cox proportional hazards modeling found that antibiotic lock was associated with a reduction in mortality (hazard ratio, 0.36; 95% confidence interval, 0.22 to 0.58 in unadjusted analyses; hazard ratio, 0.32; 95% confidence interval, 0.14 to 0.75 after multivariate adjustment). The rate of gentamicin-resistant organisms decreased (0.40/1000 person-years to 0.22/1000 person-years) in the antibiotic lock period (P=0.01). CONCLUSIONS: The results of this study show that the use of a prophylactic, gentamicin/citrate lock was associated with a substantial reduction in catheter-related bloodstream infection and is the first to report a survival advantage of antibiotic lock in a population at high risk of infection-related morbidity and mortality.
BACKGROUND AND OBJECTIVES:Infection is the second leading cause of death in hemodialysis patients. Catheter-related bloodstream infection and infection-related mortality have not improved in this population over the past two decades. This study evaluated the impact of a prophylactic antibiotic lock solution on the incidence of catheter-related bloodstream infection and mortality. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This prospective, multicenter, observational cohort study compared the effectiveness of two catheter locking solutions (gentamicin/citrate versus heparin) in 555 hemodialysis patients dialyzing with a tunneled cuffed catheter between 2008 and 2011. The groups were not mutually exclusive. Rates of catheter-related bloodstream infection and mortality hazards were compared between groups. RESULTS: The study population (n=555 and 1350 catheters) had a median age of 62 years (interquartile range=41-83 years), with 50% men and 71% black. There were 427 patients evaluable in the heparin period (84,326 days) and 322 patients evaluable in the antibiotic lock period (71,192 days). Catheter-related bloodstream infection in the antibiotic lock period (0.45/1000 catheter days) was 73% lower than the heparin period (1.68/1000 catheter days; P=0.001). Antibiotic lock use was associated with a decreased risk of catheter-related bloodstream infection compared with heparin (risk ratio, 0.23; 95% confidence interval, 0.13 to 0.38 after multivariate adjustment). Cox proportional hazards modeling found that antibiotic lock was associated with a reduction in mortality (hazard ratio, 0.36; 95% confidence interval, 0.22 to 0.58 in unadjusted analyses; hazard ratio, 0.32; 95% confidence interval, 0.14 to 0.75 after multivariate adjustment). The rate of gentamicin-resistant organisms decreased (0.40/1000 person-years to 0.22/1000 person-years) in the antibiotic lock period (P=0.01). CONCLUSIONS: The results of this study show that the use of a prophylactic, gentamicin/citrate lock was associated with a substantial reduction in catheter-related bloodstream infection and is the first to report a survival advantage of antibiotic lock in a population at high risk of infection-related morbidity and mortality.
Authors: Robert M Q Shanks; Jennifer L Sargent; Raquel M Martinez; Martha L Graber; George A O'Toole Journal: Nephrol Dial Transplant Date: 2006-04-20 Impact factor: 5.992
Authors: Marcel C Weijmer; Marinus A van den Dorpel; Peter J G Van de Ven; Pieter M ter Wee; Jos A C A van Geelen; Johannes O Groeneveld; Brigitte C van Jaarsveld; Marjon G Koopmans; Caatje Y le Poole; Anita M Schrander-Van der Meer; Carl E H Siegert; Koen J F Stas Journal: J Am Soc Nephrol Date: 2005-07-20 Impact factor: 10.121
Authors: Elizabeth L Hannah; Kurt B Stevenson; Connie A Lowder; Michael J Adcox; Robert L Davidson; Michael C Mallea; Nagraj Narasimhan; Jon P Wagnild Journal: Infect Control Hosp Epidemiol Date: 2002-09 Impact factor: 3.254
Authors: Charmaine E Lok; Kenneth E Stanley; Janet E Hux; Robert Richardson; Sheldon W Tobe; John Conly Journal: J Am Soc Nephrol Date: 2003-01 Impact factor: 10.121
Authors: J Chandra; L Long; N Isham; P K Mukherjee; G DiSciullo; K Appelt; M A Ghannoum Journal: Antimicrob Agents Chemother Date: 2018-07-27 Impact factor: 5.191
Authors: Lisa M Miller; Edward Clark; Christine Dipchand; Swapnil Hiremath; Joanne Kappel; Mercedeh Kiaii; Charmaine Lok; Rick Luscombe; Louise Moist; Matthew Oliver; Jennifer MacRae Journal: Can J Kidney Health Dis Date: 2016-09-27
Authors: Ingrid C McCall; Nilang Shah; Adithi Govindan; Fernando Baquero; Bruce R Levin Journal: Antimicrob Agents Chemother Date: 2019-06-24 Impact factor: 5.191
Authors: Amy Barton Pai; Adinoyi Garba; Paul Neumann; Alexander J Prokopienko; Gabrielle Costello; Michael C Dean; Sriram Narsipur Journal: Front Med (Lausanne) Date: 2018-11-05